Semin Respir Crit Care Med 2021; 42(02): 299-307
DOI: 10.1055/s-0041-1722964
Review Article

Determinants and Management of the Post–Pulmonary Embolism Syndrome

Gudula J.A.M. Boon
1   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
,
Menno V. Huisman
1   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
,
Frederikus A. Klok
1   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
› Author Affiliations

Abstract

Acute pulmonary embolism (PE) is not only a serious and potentially life-threatening disease in the acute phase, in recent years it has become evident that it may also have a major impact on a patient's daily life in the long run. Persistent dyspnea and impaired functional status are common, occurring in up to 50% of PE survivors, and have been termed the post-PE syndrome (PPES). Chronic thromboembolic pulmonary hypertension is the most feared cause of post-PE dyspnea. When pulmonary hypertension is ruled out, cardiopulmonary exercise testing can play a central role in investigating the potential causes of persistent symptoms, including chronic thromboembolic pulmonary disease or other cardiopulmonary conditions. Alternatively, it is important to realize that post-PE cardiac impairment or post-PE functional limitations, including deconditioning, are present in a large proportion of patients. Health-related quality of life is strongly influenced by PPES, which emphasizes the importance of persistent limitations after an episode of acute PE. In this review, physiological determinants and the diagnostic management of persistent dyspnea after acute PE are elucidated.



Publication History

Article published online:
06 February 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Huisman MV, Barco S, Cannegieter SC. et al. Pulmonary embolism. Nat Rev Dis Primers 2018; 4: 18028
  • 2 Klok FA, Zondag W, van Kralingen KW. et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med 2010; 181 (05) 501-506
  • 3 Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A. et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017; 49 (02) 1601792
  • 4 Kahn SR, Hirsch AM, Akaberi A. et al. Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE Prospective Cohort Study. Chest 2017; 151 (05) 1058-1068
  • 5 Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev 2014; 28 (06) 221-226
  • 6 Sista AK, Klok FA. Late outcomes of pulmonary embolism: the post-PE syndrome. Thromb Res 2018; 164: 157-162
  • 7 Rolving N, Brocki BC, Andreasen J. Coping with everyday life and physical activity in the aftermath of an acute pulmonary embolism: a qualitative study exploring patients' perceptions and coping strategies. Thromb Res 2019; 182: 185-191
  • 8 Chuang LH, Gumbs P, van Hout B. et al. Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Qual Life Res 2019; 28 (08) 2111-2124
  • 9 Tavoly M, Utne KK, Jelsness-Jørgensen LP. et al. Health-related quality of life after pulmonary embolism: a cross-sectional study. BMJ Open 2016; 6 (11) e013086
  • 10 Tavoly M, Wik HS, Sirnes PA. et al. The impact of post-pulmonary embolism syndrome and its possible determinants. Thromb Res 2018; 171: 84-91
  • 11 Klok FA, van Kralingen KW, van Dijk AP. et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest 2010; 138 (06) 1432-1440
  • 12 Pugliese SC, Kawut SM. The post-pulmonary embolism syndrome: real or ruse?. Ann Am Thorac Soc 2019; 16 (07) 811-814
  • 13 Lutsey PL, Windham BG, Misialek JR. et al. Long-term association of venous thromboembolism with frailty, physical functioning, and quality of life: the atherosclerosis risk in communities study. J Am Heart Assoc 2020; 9 (12) e015656
  • 14 Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism. Respir Med 2010; 104 (11) 1744-1749
  • 15 Stevinson BG, Hernandez-Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J 2007; 28 (20) 2517-2524
  • 16 Kline JA, Steuerwald MT, Marchick MR, Hernandez-Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest 2009; 136 (05) 1202-1210
  • 17 Konstantinides SV, Vicaut E, Danays T. et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol 2017; 69 (12) 1536-1544
  • 18 Barco S, Russo M, Vicaut E. et al. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Clin Res Cardiol 2019; 108 (07) 772-778
  • 19 Chow V, Ng AC, Seccombe L. et al. Impaired 6-min walk test, heart rate recovery and cardiac function post pulmonary embolism in long-term survivors. Respir Med 2014; 108 (10) 1556-1565
  • 20 Hsu C-H, Lin C-C, Li W-T, Chang H-Y, Chang W-T. Right ventricular dysfunction is associated with the development of chronic thromboembolic pulmonary hypertension but not with mortality post-acute pulmonary embolism. Medicine (Baltimore) 2019; 98 (48) e17953
  • 21 Sista AK, Miller LE, Kahn SR, Kline JA. Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: systematic review with meta-analysis. Vasc Med 2017; 22 (01) 37-43
  • 22 Klok FA, Romeih S, Kroft LJ, Westenberg JJ, Huisman MV, de Roos A. Recovery of right and left ventricular function after acute pulmonary embolism. Clin Radiol 2011; 66 (12) 1203-1207
  • 23 Klok FA, Romeih S, Westenberg JJ, Kroft LJ, Huisman MV, de Roos A. Pulmonary flow profile and distensibility following acute pulmonary embolism. J Cardiovasc Magn Reson 2011; 13: 14
  • 24 Konstantinides SV, Barco S, Rosenkranz S. et al. Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study. J Thromb Thrombolysis 2016; 42 (04) 600-609
  • 25 Rudski LG, Lai WW, Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23 (07) 685-713 , quiz 786–788
  • 26 Keller K, Tesche C, Gerhold-Ay A. et al. Quality of life and functional limitations after pulmonary embolism and its prognostic relevance. J Thromb Haemost 2019; 17 (11) 1923-1934
  • 27 Dzikowska-Diduch O, Kostrubiec M, Kurnicka K. et al. The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism. Thromb Res 2020; 186: 30-35
  • 28 Herdy AH, Ritt LE, Stein R. et al. Cardiopulmonary exercise test: background, applicability and interpretation. Arq Bras Cardiol 2016; 107 (05) 467-481
  • 29 Frost A, Badesch D, Gibbs JSR. et al. Diagnosis of pulmonary hypertension. Eur Respir J 2019; 53 (01) 1801904
  • 30 Wasserman K. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 5th ed.. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2012
  • 31 Albaghdadi MS, Dudzinski DM, Giordano N. et al. Cardiopulmonary exercise testing in patients following massive and submassive pulmonary embolism. J Am Heart Assoc 2018; 7 (05) 7
  • 32 Huang D, Guo J, Yang W, Liu J. Exercise capacity and ventilatory efficiency in patients with pulmonary embolism after short duration of anticoagulation therapy. Am J Med Sci 2020; 359 (03) 140-146
  • 33 Fernandes TM, Alotaibi M, Strozza DM. et al. Dyspnea postpulmonary embolism from physiological dead space proportion and stroke volume defects during exercise. Chest 2020; 157 (04) 936-944
  • 34 Guazzi M, Adams V, Conraads V. et al; European Association for Cardiovascular Prevention & Rehabilitation, American Heart Association. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2012; 126 (18) 2261-2274
  • 35 McCabe C, Deboeck G, Harvey I. et al. Inefficient exercise gas exchange identifies pulmonary hypertension in chronic thromboembolic obstruction following pulmonary embolism. Thromb Res 2013; 132 (06) 659-665
  • 36 Held M, Kolb P, Grün M. et al. Functional characterization of patients with chronic thromboembolic disease. Respiration 2016; 91 (06) 503-509
  • 37 van Kan C, van der Plas MN, Reesink HJ. et al. Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease. J Thorac Cardiovasc Surg 2016; 152 (03) 763-771
  • 38 Guth S, Wiedenroth CB, Rieth A. et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J 2018; 52 (03) 1800458
  • 39 Claeys M, Claessen G, La Gerche A. et al. Impaired cardiac reserve and abnormal vascular load limit exercise capacity in chronic thromboembolic disease. JACC Cardiovasc Imaging 2019; 12 (8, Pt 1): 1444-1456
  • 40 Swietlik EM, Ruggiero A, Fletcher AJ. et al. Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension. Eur Respir J 2019; 53 (01) 53
  • 41 Cosmi B, Nijkeuter M, Valentino M, Huisman MV, Barozzi L, Palareti G. Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism. Intern Emerg Med 2011; 6 (06) 521-528
  • 42 Alonso-Martínez JL, Anniccherico-Sánchez FJ, Urbieta-Echezarreta MA, García-Sanchotena JL, Herrero HG. Residual pulmonary thromboemboli after acute pulmonary embolism. Eur J Intern Med 2012; 23 (04) 379-383
  • 43 den Exter PL, van Es J, Kroft LJ. et al; Prometheus Follow-Up Investigators. Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost 2015; 114 (01) 26-34
  • 44 Hvid-Jacobsen K, Fogh J, Nielsen SL, Thomsen HS, Hartling OJ. Scintigraphic control of pulmonary embolism. Eur J Nucl Med 1988; 14 (02) 71-72
  • 45 Sanchez O, Helley D, Couchon S. et al. Perfusion defects after pulmonary embolism: risk factors and clinical significance. J Thromb Haemost 2010; 8 (06) 1248-1255
  • 46 Planquette B, Ferré A, Peron J. et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study. Thromb Res 2016; 148: 70-75
  • 47 Pesavento R, Filippi L, Palla A. et al; SCOPE Investigators. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 2017; 49 (05) 49
  • 48 Raj L, Robin P, Le Mao R. et al; PADIS-PE Investigators. Predictors for residual pulmonary vascular obstruction after unprovoked pulmonary embolism: implications for clinical practice—the PADIS-PE trial. Thromb Haemost 2019; 119 (09) 1489-1497
  • 49 Wan T, Rodger M, Zeng W. et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: results from the REVERSE cohort study. Thromb Res 2018; 162: 104-109
  • 50 Poli D, Cenci C, Antonucci E. et al. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy. Thromb Haemost 2013; 109 (02) 181-186
  • 51 Ma KA, Kahn SR, Akaberi A. et al. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: results of the ELOPE Study. Res Pract Thromb Haemost 2018; 2: 670-677
  • 52 Le Gal G, Carrier M, Castellucci LA. et al; for the ISTH CDE Task Force. Development and implementation of common data elements for venous thromboembolism research: Official Communication from the SSC of the ISTH. J Thromb Haemost 2021; 19: 297-303
  • 53 Kim NH, Delcroix M, Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53 (01) 1801915
  • 54 Simonneau G, Torbicki A, Dorfmuller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir J 2017; 26: 160112
  • 55 Galiè N, Humbert M, Vachiery JL. et al; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37 (01) 67-119
  • 56 Simonneau G, Montani D, Celermajer DS. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53 (01) 1801913
  • 57 Taboada D, Pepke-Zaba J, Jenkins DP. et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44 (06) 1635-1645
  • 58 Klok FA, Couturaud F, Delcroix M, Humbert M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J 2020; 55 (06) 55
  • 59 Delcroix M, Kerr K, Fedullo P. Chronic thromboembolic pulmonary hypertension. Epidemiology and risk factors. Ann Am Thorac Soc 2016; 13 (Suppl. 03) S201-S206
  • 60 Pepke-Zaba J, Delcroix M, Lang I. et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124 (18) 1973-1981
  • 61 Barco S, Klok FA, Konstantinides SV. et al. Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry. J Thromb Haemost 2020; 18 (01) 151-161
  • 62 Ende-Verhaar YM, van den Hout WB, Bogaard HJ. et al. Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost 2018; 16 (11) 2168-2174
  • 63 Schweikert B, Pittrow D, Vizza CD. et al. Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries. BMC Health Serv Res 2014; 14: 246
  • 64 Delcroix M, Lang I, Pepke-Zaba J. et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 2016; 133 (09) 859-871
  • 65 Klok FA, Barco S, Konstantinides SV. et al. Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry. Eur Respir J 2018; 52 (06) 1801687
  • 66 McCabe C, White PA, Hoole SP. et al. Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter. J Appl Physiol (1985) 2014; 116 (04) 355-363
  • 67 Donahoe L, Vanderlaan R, Thenganatt J. et al. Symptoms are more useful than echocardiography in patient selection for pulmonary endarterectomy. Ann Thorac Surg 2017; 104 (04) 1179-1185
  • 68 Wiedenroth CB, Olsson KM, Guth S. et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease. Pulm Circ 2018; 8 (01) 2045893217753122
  • 69 Inami T, Kataoka M, Kikuchi H, Goda A, Satoh T. Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest. Int J Cardiol 2019; 289: 116-118
  • 70 McCabe C, Dimopoulos K, Pitcher A. et al. Chronic thromboembolic disease following pulmonary embolism: time for a fresh look at old clot. Eur Respir J 2020; 55 (04) 55
  • 71 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
  • 72 American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277
  • 73 Ortel TL, Neumann I, Ageno W. et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4 (19) 4693-4738
  • 74 Vonk Noordegraaf A, Chin KM, Haddad F. et al. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 2019; 53 (01) 1801900
  • 75 Boon GJAM, Bogaard HJ, Klok FA. Essential aspects of the follow-up after acute pulmonary embolism: an illustrated review. Res Pract Thromb Haemost 2020; 4: 958-968
  • 76 Klok FA, Delcroix M, Bogaard HJ. Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism. J Thromb Haemost 2018; 16 (06) 1040-1051
  • 77 Klok FA, Tijmensen JE, Haeck ML, van Kralingen KW, Huisman MV. Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: results of a questionnaire. Eur J Intern Med 2008; 19 (08) 625-629
  • 78 Nopp S, Klok FA, Moik F. et al. Outpatient pulmonary rehabilitation in patients with persisting symptoms after pulmonary embolism. J Clin Med 2020; 9 (06) 9
  • 79 Noack F, Schmidt B, Amoury M. et al. Feasibility and safety of rehabilitation after venous thromboembolism. Vasc Health Risk Manag 2015; 11: 397-401
  • 80 Amoury M, Noack F, Kleeberg K. et al. Prognosis of patients with pulmonary embolism after rehabilitation. Vasc Health Risk Manag 2018; 14: 183-187
  • 81 Lakoski SG, Savage PD, Berkman AM. et al. The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial. J Thromb Haemost 2015; 13 (07) 1238-1244
  • 82 Kirchberger I, Ruile S, Linseisen J, Haberl S, Meisinger C, Berghaus TM. The lived experience with pulmonary embolism: a qualitative study using focus groups. Respir Med 2020; 167: 105978
  • 83 Hunter R, Noble S, Lewis S, Bennett P. Long-term psychosocial impact of venous thromboembolism: a qualitative study in the community. BMJ Open 2019; 9 (02) e024805
  • 84 Hunter R, Lewis S, Noble S, Rance J, Bennett PD. “Post-thrombotic panic syndrome”: a thematic analysis of the experience of venous thromboembolism. Br J Health Psychol 2017; 22 (01) 8-25
  • 85 Bonderman D, Wilkens H, Wakounig S. et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J 2009; 33 (02) 325-331
  • 86 Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013; 41 (02) 462-468
  • 87 Guérin L, Couturaud F, Parent F. et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 2014; 112 (03) 598-605
  • 88 Ende-Verhaar YM, Meijboom LJ, Kroft LJM. et al. Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study. J Heart Lung Transplant 2019; 38 (07) 731-738
  • 89 Lachant D, Bach C, Wilson B. et al. Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus. Pulm Circ 2020; 10 (03) 2045894020952019
  • 90 Klok FA, Barco S, Siegerink B. Measuring functional limitations after venous thromboembolism: a call to action. Thromb Res 2019; 178: 59-62
  • 91 Boon GJAM, Barco S, Bertoletti L. et al. Measuring functional limitations after venous thromboembolism: optimization of the Post-VTE Functional Status (PVFS) Scale. Thromb Res 2020; 190: 45-51
  • 92 Konstantinides SV, Meyer G, Becattini C. et al; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J 2019; 54 (03) 1901647
  • 93 Helmersen D, Provencher S, Hirsch AM. et al. Diagnosis of chronic thromboembolic pulmonary hypertension: a Canadian Thoracic Society clinical practice guideline update. Can J Respir Crit Care Sleep Med 2019; 3: 177-198
  • 94 Danielsbacka JS, Hansson PO, Mannerkorpi K, Olsén MF. Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study. Thromb Res 2020; 189: 55-60
  • 95 Kahn SR, Akaberi A, Granton JT. et al. Quality of life, dyspnea, and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE cohort study. Am J Med 2017; 130: 990.e9-e21
  • 96 Samaranayake CB, Royle G, Jackson S, Yap E. Right ventricular dysfunction and pulmonary hypertension following sub-massive pulmonary embolism. Clin Respir J 2017; 11 (06) 867-874
  • 97 Xi Q, Zhao Z, Liu Z, Ma X, Luo Q, Liu W. The lowest VE/VCO2 ratio best identifies chronic thromboembolic pulmonary hypertension. Thromb Res 2014; 134 (06) 1208-1213
  • 98 Dentali F, Bertolini A, Nicolini E. et al. Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging. Intern Emerg Med 2013; 8 (08) 689-694
  • 99 Yan WW, Wang LM, Che L. et al. Quantitative evaluation of cardiopulmonary functional reserve in treated patients with pulmonary embolism. Chin Med J (Engl) 2012; 125 (03) 465-469
  • 100 Fasullo S, Scalzo S, Maringhini G. et al. Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 2011; 341 (01) 33-39
  • 101 Golpe R, Pérez-de-Llano LA, Castro-Añón O. et al. Right ventricle dysfunction and pulmonary hypertension in hemodynamically stable pulmonary embolism. Respir Med 2010; 104 (09) 1370-1376
  • 102 Kjaergaard J, Schaadt BK, Lund JO, Hassager C. Prognostic importance of quantitative echocardiographic evaluation in patients suspected of first non-massive pulmonary embolism. Eur J Echocardiogr 2009; 10 (01) 89-95
  • 103 Ciurzyński M, Kurzyna M, Bochowicz A. et al. Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity. Clin Cardiol 2004; 27 (12) 693-697
  • 104 Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 1999; 99 (10) 1325-1330